O58. Longterm Outcomes of Children Born to Mothers with SLE Exposed to Hydroxychloroquine in Pregnancy
Mary Gayed(University Hospitals Birmingham NHS Foundation Trust), Caroline Gordon(Royal National Hospital for Rheumatic Diseases), N. Mc Hugh(Royal National Hospital for Rheumatic Diseases), F. Leone, Ian Giles(University College Hospital), Munther A. Khamashta(The King's College), Ian N Bruce(University of Manchester), V. Toescu(University of Birmingham), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Lee‐Suan Teh(Blackburn College), Mohammed Akil, David Culliford(Nuffield Orthopaedic Centre)
Cited by 8
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
The “Primary” Antiphospholipid Syndrome
|Medicine|1989|963